We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
Latest News
AI's New Bottleneck: GridAI Tackles Energy Control for Data Centers
about 2 hours ago

A2Z Smart Carts Reveal Hidden Shopper Behavior to Transform Retail
about 3 hours ago

New Stroke Drug Cuts Recurrence Risk 26% Without Bleeding Danger
about 4 hours ago

MedCognetics' AI Breast Imaging Tool Gets FDA Clearance
about 5 hours ago

HR News
JDXpert Launches JDX+: AI-Powered Platform Solves Job Data Chaos
about 13 hours ago
HR Study: Talent Acquisition Crisis Costs Firms Billions, AI Offers Hope
1 day ago
OrangeHRM 8.0 Launches with Citra AI to Transform HR into Culture Architects
1 day ago
HR.com Partners with VirgilHR to Revolutionize HR Compliance Technology
3 days ago
AI Hiring Bias Exposed: New 2026 Laws Protect Job Seekers from Algorithmic Discrimination
4 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 8 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 8 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 4 months
Ucore Advances Western Rare Earth Supply Chain to Counter China's Dominance
about 1 hour ago
Datavault AI Unveils 2026 Strategy: Scaling Edge Infrastructure & Data Monetization
about 1 hour ago
Crypto News
SOLOWIN Expands Digital Asset Operations into Korea and Japan
about 6 hours ago
Blockchain Fuels Copper Tokenization Surge as Metals Market Evolves
about 7 hours ago
Chinese Crime Networks Linked to $16B Crypto Crimes in Chainalysis Report
about 7 hours ago
UAE Royal's Trump Crypto Investment Sparks Scrutiny Amid Industry Push
about 7 hours ago
Datavault AI to Distribute Dream Bowl Meme Coin II to Shareholders
1 day ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 8 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 8 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 4 months
LIXTE Biotechnology Targets Cancer Treatment Resistance with Novel Enhancement Strategy
about 2 hours ago
New Stroke Drug Cuts Recurrence Risk 26% Without Bleeding Danger
about 4 hours ago
Technology News
Ucore Advances Western Rare Earth Supply Chain to Counter China's Dominance
about 1 hour ago
Datavault AI Unveils 2026 Strategy: Scaling Edge Infrastructure & Data Monetization
about 1 hour ago
AI's Next Bottleneck: Electricity Management Becomes Critical Constraint
about 2 hours ago
AI's New Bottleneck: GridAI Tackles Energy Control for Data Centers
about 2 hours ago
A2Z Smart Carts Reveal Hidden Shopper Behavior to Transform Retail
about 3 hours ago
Events & Conferences
Comedy Village Hosts Valentine's Day Laughs with Top Comedians
31 minutes ago
Massimo Group Expands Fleet Sales with HVAC Pro Series at 2026 Golf Conference
about 6 hours ago
Surgeon's Accident Reveals Healthcare's Self-Care Crisis for Women
about 13 hours ago
Future Stars Summer Camp Earns Prestigious ACA Accreditation for 2026
about 13 hours ago
JASDFW Launches New Website, Announces Sun & Star Gala Honoring Governor Abbott
about 13 hours ago






